[HTML][HTML] New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis

H Li, D Wang, Y Yuan, J Min - Arthritis research & therapy, 2017 - Springer
Osteoarthritis (OA) is the most common joint disorder and affects approximately half of the
aged population. Current treatments for OA are largely palliative until the articular cartilage …

The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review

ESE Mehana, AF Khafaga, SS El-Blehi - Life sciences, 2019 - Elsevier
Extensive degeneration of articular cartilage (AC) is a primary event in the pathogenesis of
osteoarthritis (OA) and other types of joint and bone inflammation. OA results in the loss of …

[HTML][HTML] Overview of MMP-13 as a promising target for the treatment of osteoarthritis

Q Hu, M Ecker - International journal of molecular sciences, 2021 - mdpi.com
Osteoarthritis (OA) is a common degenerative disease characterized by the destruction of
articular cartilage and chronic inflammation of surrounding tissues. Matrix metalloproteinase …

Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis

MB Goldring - Therapeutic advances in musculoskeletal …, 2012 - journals.sagepub.com
Chondrogenesis occurs as a result of mesenchymal cell condensation and
chondroprogenitor cell differentiation. Following chondrogenesis, the chondrocytes remain …

Joint diseases and matrix metalloproteinases: a role for MMP-13

H Takaishi, T Kimura, S Dalal, Y Okada… - Current …, 2008 - ingentaconnect.com
The role of matrix metalloproteinases in disease has been investigated over the last two
decades. A focus on this family of proteases is particularly emphasized in two major …

Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis

HE Barksby, JM Milner, AM Patterson… - … : Official Journal of …, 2006 - Wiley Online Library
Objective We have previously reported the up‐regulation of matrix metalloproteinase 10
(MMP‐10) following treatment with the procatabolic stimulus of interleukin‐1 (IL‐1) and …

Matrix metalloproteinases in arthritis: towards precision medicine

B Grillet, RVS Pereira, J Van Damme… - Nature Reviews …, 2023 - nature.com
Proteolysis of structural molecules of the extracellular matrix (ECM) is an irreversible post-
translational modification in all arthropathies. Common joint disorders, including …

[HTML][HTML] Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects

AR Johnson, AG Pavlovsky, DF Ortwine, F Prior… - Journal of biological …, 2007 - ASBMB
Matrix metalloproteinase-13 (MMP13) is a Zn 2+-dependent protease that catalyzes the
cleavage of type II collagen, the main structural protein in articular cartilage. Excess MMP13 …

Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade

R Dreier, S Grässel, S Fuchs, J Schaumburger… - Experimental cell …, 2004 - Elsevier
In joint diseases of both the inflammatory (rheumatoid arthritis, or RA) or the degenerative
variety (osteoarthritis, or OA), matrix metalloproteinases (MMPs) are essential mediators of …

Matrix metalloproteinase 13–deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development

CB Little, A Barai, D Burkhardt, SM Smith… - … : Official Journal of …, 2009 - Wiley Online Library
Objective To investigate the role of matrix metalloproteinase 13 (MMP‐13; collagenase 3) in
osteoarthritis (OA). Methods OA was surgically induced in the knees of MMP‐13–knockout …